Advancing Genomics for Drug Development and Safety Evaluation

摘要

This special issue is focused on advancing genomics for drug development and safety evaluation. Gaining wide adoption in biomedical fields, genomic technologies have tremendously improved our molecular understanding of disease etiology and pathogenesis. Furthermore, the accumulated genomic datasets allow us to articulate new hypothesis, revisit and rethink the conventional paradigm for drug development and safety evaluation, and generate more efficient tools to promote biomedical researches.